Skip to content
    CRVS stock page

    Corvus Pharmaceuticals, Inc.

    CRVS · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 06, 2026

      Corvus Q2 FY26 — Socalitinib Pipeline Progress and Atopic Dermatitis Efficacy

      Read the brief

    Browse all US companies on the earnings-call register.